CAI- Caris Life Sciences, Inc.

Trade Summary

1 week ago, Spetzler David Baxley, serving as President at Caris Life Sciences, Inc. (CAI), sold 597,212 shares at $24.84 per share, for a total transaction value of $14,834,106.63. Following this transaction, Spetzler David Baxley now holds 1,182,871 shares of CAI.

This sale represents a 33.55% decrease in Spetzler David Baxley's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, September 3, 2026 and publicly disclosed via SEC Form 4 filing on Friday, September 4, 2026 at 4:59 PM ET, 1 day after the trade was made.

Caris Life Sciences, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.